search icon

    Market Snapshot

    • S&P Futures

      4,132.75

    • Dow Futures

      32,794

    • Nasdaq Futures

      13,103.75

    blog search icon

    Aprea Therapeutics, Inc.

    (NASDAQ:APRE)

    $0.98

    -$0.01

    -1.08%

    Aprea Therapeutics, Inc. Chart

    APRE Stock Price Today

    Aprea Therapeutics, Inc. (APRE) stock declined over -1.08% intraday to trade at $0.9793 a share on NASDAQ. The stock opened with a gain of 2.01% at $1 and touched an intraday high of $1.16, falling -1.08% against the last close of $0.99. The stock went to a low of $0.971 during the session.

    Stock Snapshot

    $0.99

    Prev. Close

    21.96 Million

    Market Cap

    $0.971

    Day Low

    $1

    Open

    21.9 Million

    Number of Shares

    $1.16

    Day High

    -

    P/E ratio

    -1.65

    EPS (TTM)

    2.17

    Cash Flow per Share

    9.82

    Free Float in %

    2.50

    Book Value

    341,300

    Volume

    Aprea Therapeutics, Inc. Historical Data

    DateOpenHighLowCloseVolume
    2022-08-08$1$1.16$0.971$0.979341,300
    2022-08-05$0.96$1$0.922$0.9978,500
    2022-08-04$0.95$0.97$0.924$0.95111,800
    2022-08-03$0.92$0.98$0.913$0.9471,400
    2022-08-02$0.95$0.975$0.91$0.923126,200
    2022-08-01$0.922$0.98$0.912$0.9598,600
    2022-07-29$1.07$1.08$0.913$0.96483,600
    2022-07-28$1.1$1.109$1.07$1.09114,000
    2022-07-27$1.1$1.11$1.08$1.1192,300
    2022-07-26$1.11$1.128$1.07$1.08170,500

    Contact Details

    535 Boylston Street
    Boston, MA 02116
    United States

    Webiste:APRE

    617 463 9385

    Company Information

    Employees-

    Beta-

    Sales or Revenue0

    5Y Sales Change-

    Fiscal Year Ends2021-12-30

    SectorHealth Care

    IndustryBiotechnology

    About Company

    Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapeutics that reactivate mutant p53 tumor suppressor protein. The company's lead product candidate is APR-246 (Eprenetapopt), a small molecule p53 reactivator that is in late-stage clinical development for the treatment of hematologic malignancies, including myelodysplastic syndromes (MDS) and acute myeloid leukemia, as well as for relapsed/refractory TP53 mutant chronic lymphoid leukemia; and gastric, bladder, and non-small cell lung cancers. It also develops APR-548, a p53 reactivator that is on Phase I dose-escalation clinical trial for oral administration in MDS patients. The company was founded in 2006 and is headquartered in Boston, Massachusetts.

    Frequently Asked Questions

    icon

    What is the current Aprea Therapeutics, Inc. (APRE) stock price?

    Aprea Therapeutics, Inc. (NASDAQ: APRE) stock price is $0.9793 as of the last check on Monday, August 8. During the trading session, APRE stock reached the peak price of $1.16 while $0.971 was the lowest point it dropped to.

    icon

    APRE's industry and sector of operation?

    The NASDAQ listed APRE is part of Biotechnology industry that operates in the broader Health Care sector. Aprea Therapeutics, Inc. , a clinical-stage biopharmaceutical company, develops and commercializes cancer therapeutics that reactivate mutant p53 tumor suppressor protein.

    icon

    Who are the executives of APRE?

    Mr. Christian S. Schade
    Pres, CEO & Chairman
    Mr. Scott M. Coiante
    Sr. VP, Company Sec. & CFO
    Dr. Eyal C. Attar M.D.
    Sr. VP & Chief Medical Officer
    Dr. Lars B. Abrahmsen
    Sr. VP & Chief Scientific Officer

    icon

    What is the APRE stock price today?

    APRE stock traded closed the last session at $0.979, which is -$0.010700000000000043 or -1.080808080808085% lower than its previous close of $0.99. APRE's current trading price is 57.95% lower than its 52-week high of $5.67 where as its distance from 52-week low of 0.62% is -82.73%.

    icon

    How many employees does APRE have?

    Number of APRE employees currently stands at -. APRE operates from 535 Boylston Street, Boston, MA 02116, United States.

    icon

    Link for APRE official website?

    Official Webiste of $APRE is: https://www.aprea.com

    icon

    How do I contact APRE?

    APRE could be contacted at APRE operates from 535 Boylston Street, Boston, MA 02116, United States, or at phone #617 463 9385 and can also be accessed through its website.

    icon

    How many shares of APRE are traded daily?

    APRE stock volume for the day was 341,300 shares while in the previous session number of APRE shares traded was 341,300 . The average number of APRE shares traded daily for last 3 months was 916.65 Thousands.

    icon

    How much did APRE change today?

    The percentage change in APRE stock occurred in the recent session was -1.080808080808085% while the dollar amount for the price change in APRE stock was -$0.010700000000000043.

    icon

    What price range APRE stock been trading in?

    In the recent session, the day high for APRE stock was $1.16 while the low for APRE stock touched on the day was $0.971.

    icon

    What is the market cap of APRE currently?

    The market value of APRE currently stands at 21.96 Million with its latest stock price at $0.9793 and 21.9 Million of its shares outstanding.